alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › neuroimaging

neuroimaging

5 studies tagged neuroimaging, dated 2005-04-01 to 2024-03-27. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer's Disease 2024-03-27
  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework 2023-07-12
  3. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis 2020-09-02

Studies

5 studies carry this tag.

Date range

2005 to 2024

Top journals

  • CNS neuroscience & therapeutics 1
  • Diagnostics (Basel, Switzerland) 1
  • Functional neurology 1
  • Neurobiology of disease 1
  • Neuroscience letters 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Diagnostics (Basel, Switzerland) 2024-03-27 Biomarkers

    An improved understanding of the pathobiology of Alzheimer's disease (AD) should lead ultimately to an earlier and more accurate diagnosis of AD, providing the opportunity to intervene earlier in the disease process and to improve outcomes.

  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. CNS neuroscience & therapeutics 2023-07-12 Biomarkers

    Our findings suggest that plasma, CSF, and neuroimaging biomarkers differ considerably within the ATN framework; the most accurate target biomarkers for diagnosing AD were the CSF-A, neuroimaging-T, and neuroimaging-N within each ATN modality.

  3. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neurobiology of disease 2020-09-02 TREM2 and immune genetics

    Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) have a strong clinical, genetic and pathological overlap.

  4. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neuroscience letters 2010-11-19 Biomarkers

    Familial Alzheimer's disease (AD) due to PSEN1 mutations provides an opportunity to examine AD biomarkers in persons in whom the diagnosis is certain.

  5. Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Functional neurology 2005-04-01 TREM2 and immune genetics

    Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and bone cysts.

All topic tags with their study counts